<?xml version='1.0' encoding='utf-8'?>
<record xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
			<header>
				<identifier>oai:regsci-ojs-tamu.tdl.org:article/51</identifier>
				<datestamp>2023-04-10T23:42:58Z</datestamp>
				<setSpec>regsci:PC</setSpec>
			</header>
			<metadata>
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">Regulation of Pharmaceuticals in Developing Nations: A Case from Nepal</dc:title>
	<dc:creator xml:lang="en">Poudel, Bhupendra Kumar</dc:creator>
	<dc:creator xml:lang="en">Ishii, Itsuko</dc:creator>
	<dc:subject xml:lang="en">Medicine Regulatory Agency</dc:subject>
	<dc:subject xml:lang="en">Developing country</dc:subject>
	<dc:subject xml:lang="en">GMP</dc:subject>
	<dc:description xml:lang="en">Department of Drug Administration (DDA), medicine regulatory authority of Nepal, is aligned towards achieving Universal Health Coverage through the regulation of medicines, pharmacies, manufacturing facilities and medicine testing laboratories from its offices located in Kathmandu, Birgunj, Biratnagar and Nepalgunj and takes legal or administrative actions as appropriate.Â  It has its own regulatory laboratory, National Medicines Laboratory for testing and analysis of medicines. Besides, DDA reports suspected ADR to Upshala Monitoring Centre, Sweden, provides drug information and conducts regulatory trainings. Unlike in the developed world, DDA may not be able to fulfill all of its objectives. But then, a mechanism of regulation of pharmaceuticals is functional and is dynamic as per national need.https://doi.org/10.21423/jrs-v04n04p018 (DOI assigned 5/14/2019)</dc:description>
	<dc:publisher xml:lang="en">Office of the Texas State Chemist</dc:publisher>
	<dc:date>2016-09-16</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://regsci-ojs-tamu.tdl.org/regsci/article/view/51</dc:identifier>
	<dc:identifier>10.21423/JRS-V04N04P018</dc:identifier>
	<dc:source xml:lang="en">Journal of Regulatory Science; Vol. 4 No. 4 (2016); 18-20</dc:source>
	<dc:source>2377-3537</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://regsci-ojs-tamu.tdl.org/regsci/article/view/51/46</dc:relation>
	<dc:rights xml:lang="en">https://creativecommons.org/licenses/by-nc/4.0</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		
